Glucose Competence of the Hepatoportal Vein Sensor Requires the Presence of an Activated Glucagon-Like Peptide-1 Receptor

Diabetes

Volumn 50, Issue 8, 2001, Pages 1720-1728

  Burcelin, Rémy ^a   Da Costa, Anabela ^a   Drucker, Daniel ^b   Thorens, Bernard ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN (9 39); EXENDIN (9-39); GASTROINTESTINAL HORMONE; GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 (7 36)AMIDE; GLUCAGON-LIKE PEPTIDE 1 (7-36)AMIDE; GLUCOSE; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; TRITIUM; VENOM;

ANIMAL; ARTICLE; C57BL MOUSE; DIET RESTRICTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL VEIN; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INDWELLING CATHETER; INTRAVENOUS DRUG ADMINISTRATION; LIVER VEIN; METABOLIC CLEARANCE RATE; METABOLISM; MOUSE; PHYSIOLOGY; PORTAL VEIN;

ANIMALS; BLOOD GLUCOSE; CATHETERS, INDWELLING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMORAL VEIN; GASTROINTESTINAL HORMONES; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; GLUCOSE; HEPATIC VEINS; HOMEOSTASIS; INFUSIONS, INTRAVENOUS; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PORTAL SYSTEM; PORTAL VEIN; PROTEIN PRECURSORS; TRITIUM; VENOMS;

EID: 0035434115     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.8.1720     Document Type: Article

References (28)

1. Niijima A: Afferent impulse discharges from glueoreceptors in the liver of the guinea pig. Ann N Y Acad Sci 157:690-700, 1969
2. Pagliassotti MJ, Myers SR, Moore MC, Neal DW, Cherrington AD: Magnitude of negative arterial-portal glucose gradient alters net hepatic glucose balance in conscious dogs. Diabetes 40:1650-1068, 1991
3. Pagliassotti MJ, Holste LC, Moore MC, Neal DW, Cherrington AD: Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J Clin Invest 97:81-91, 1996
4. Niijima A: Blood glucose levels modulate efferent activity in the vagal supply to the rat liver. J Physiol 364:105-112, 1985
5. Gardemann A, Strulik H, Jungermann K: A portal-arterial glucose concentration gradient as a signal for an insulin-dependent net glucose uptake in perfused rat liver. FEBS Lett 202:255-259, 1986
6. Stumipel F, Jungermann K: Sensing by intrahepatic muscarinic nerves of a portal-arterial glucose concentration gradient as a signal for insulin-dependent glucose uptake in the perfused rat liver. FEBS Lett 406:119-122, 1997
7. Moore MC, Rossetti L, Pagliassotti MJ, Monahan M, Venable C, Neal D, Cherrington AD: Neural and pancreatic influences on net hepatic glucose uptake and glycogen synthesis. Am J Physiol 271-E215-E222, 1996
8. Moore MC, Cherrington AD: The nerves, the liver, and the route of feeding: an integrated response to nutrient delivery. Nutrition 12:282-284, 1996
9. Shimizu N, Oomura Y, Novin D, Grijalva CV, Cooper PH: Functional correlations between lateral hypothalamic glucose-sensitive neurons and hepatic portal glucose-sensitive units in rat. Brain Res 265:49-54, 1983
10. Schmitt M: Influence of hepatic portal receptors on hypothalamic feeding and satiety centers. Am J Physiol 225:1089-1095, 1973
11. Berthoud HR, Niijima A, Sauter JF, Jeanrenaud B: Evidence for a role of the gastric, coeliac and hepatic branches in vagally stimulated insulin secretion in the rat. J Auton Nerv Syst 7:97-110, 1983
12. Adachi A, Shimizu N, Oomura Y, Kobashi M: Convergence of hepatoportal glucose-sensitive afferent signals to glucose-sensitive units within the nucleus of the solitary tract. Neurosci Lett 46:215-218, 1984
13. Hevener AL, Bergman RN, Donovan CM: Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 46:1521-1525, 1997
14. Hevener A, Bergman R, Donovan C: Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 49:8-12, 2000
15. Burcelin R, Dolci W, Thorens B: Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49:1035-1642, 2000
16. Burcelin R, Dolci W, Thorens B: Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes 49:1643-1648, 2000
17. Matschinsky FM: Banting Lecture 1995: A lesson in metabolic regulation inspired by the glucokinase paradigm. Diabetes 45:223-241, 1996
18. Holst JJ: Enteroglucagon (Review). Annu Rev Physiol 59:257-271, 1997
19. Creutzfeldt W: Entero-insular axis and diabetes mellitus. Horm Metab Res Suppl 26:8-13, 1992
20. Thorens B, Waeber G: Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM. Diabetes 42:1219-1225, 1993
21. Nishizawa M, Nakabayashi H, Uchida K, Nakagawa A, Niijima A: The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein. J Auton Nerv Syst 61:149-154, 1996
22. Nakabayashi H, Nishizawa M, Nakagawa A, Takeda R, Niijima A: Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol 271:E808-E813, 1996
23. Hansen L, Deacon C, Orskov C, Holst JJ: Glucagon like peptide-1-(7-36)aminde is transformed to glucagon like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140:5356-5363, 1999
24. Balkan B, Li X: Portal GLP1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am J Physiol 279:R1449-R1454, 2000
25. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ: Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258, 1996
26. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B: Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem 268:19650-19655, 1993
27. Serre V, Dolci W, Schaerer E, Scrocchi L, Drucker D, Efrat S, Thorens B: Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3′,5′-monophosphate levels and beta-cell glucose competence. Endocrinology 139: 4448-4454, 1998
28. Nishizawa M, Nakabayashi H, Kawai K, Ito T, Kawakami K, Nakagawa A, Niijima A, Uchida K: The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor. J Auton Nerv Syst 80:14-21, 2000